Victor Ambros and Gary Ruvkun won the Nobel for medicine for their discovery of microRNA - Copyright AFP Drew ANGERER Victor Ambros and Gary Ruvkun won the Nobel for ...
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular ...
The vector consists of a polyethylene glycolylated liposomal outer coat (providing immune evasion and prolonged circulation), a spindle-shaped nanomotor (resembling a flagellum, facilitating targeted ...
Zacks Small Cap Research on MSN
RNAZ: Introducing RNA therapeutics
By John Vandermosten, CFA NASDAQ: RNAZ READ THE FULL RNAZ RESEARCH NOTE RNA Oncology Ribonucleic acid (RNA) oncology is a specialized field in the cancer space that focuses on using RNA-based ...
The abundance and distribution of microRNAs vary vastly across different sample types, indicating their unique regulatory needs and physiological functions. In human samples, most reports suggest that ...
Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint for these cells is essentially the same. Where do those differences come ...
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results